Back to search

Institutes outside Greece

Pharmaceutical implants: drug incorporated antimicrobial sutures for medical applications

Abstract

dc:description

Surgical site infections (SSI) are common post-operative complications that patients acquire in a hospital environment during the course of treatment for other medical conditions. In surgical wounds, bacteria usually proliferate and in combination with the patient's vulnerable immune system, they can create infections that require additional medical care. Dispersion of a pharmaceutical agent into a polymeric fiber can eliminate the development of SSIs via immediate inhibition of bacterial growth caused by the sustained localized delivery of the drug molecule at the infected site, increasing its bioavailability. In this research, the first study begins with the design and development of Polyethylene-co-Vinyl Acetate (EVA) surgical sutures incorporated with Tetracycline Hydrochloride (TC HCl) for superficial tissue bonding. The fibers were prepared at a drug/polymer ratio of 25%/75% via the extrusion technique on a Davis Standard DS-10HM single screw extruder. Two different temperature profiles were applied and fibers of two different diameters and drug dispersions were collected (EVA 1 and EVA 2). TGA analysis was used to investigate their drug/polymer ratio. SEM images were taken to measure the exact diameter of the fiber sampmes and tensile testing proved their ability as surgical sutures. The second study examined the quantity of TC HCl released from the two fibers over a 10-day period. UV readings confirmed that sufficient amount of drug left the polymeric matrix during that time and Fick's second law of diffusion indicated anomalous, non-fickian diffusion model by both the fibers. Antibacterial studies showed successful Escherichia Coli (E. Coli) inhibition of three different fiber lengths. Cytotoxicity testing towards two different blood cells (HL-60, NB-4) confirmed the biocompatibility of EVA as polymeric material. The third study involved the design and development of Polycaprolactore (PCL) surgical sutures incorporated with TC HCl for internal tissue bonding. The fibers were prepared at a drug/polymer ratio of 25%/75% via the extrusion technique on the same extruder. Two different temperature profiles were applied and fibers of two different diameters and drug dispersons were collected (PCL 1 and PCL 2). TGA analysis confirmed their drug/polymer ratio. SEM images were used to measure the fibers' diameters. Tensile testing proved their potential as surgical sutures.The fourth investigation examined the quantity of TC HCl released from both the PCL 1 and 2 fibers over a period of 10 days. PCL 1 fiber performed an anomalous diffusion while PCL 2 fiber showed Fickian diffusion profile. Antibacterial studies on three different length of both fibers proved their bacterial inhibition abilities against E. Coli, when the fibers were left in liquid cultures for 48 hours, when they were introduced into fresh bacterial cultures every 24 hours and when they were immersed in liquid cultures of higher concentrations. Cytotoxicity data confirmed the PCL's biocompativle properties as a medical device component since this allowed regular cell growth of two different types of blood cells (HL-60, NB-4).

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fylaktou, Evanthia
  • Φυλακτού, Ευανθία

Subjects

dc:subject × 29

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61852

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fylaktou, Evanthia; Φυλακτού, Ευανθία. Pharmaceutical implants: drug incorporated antimicrobial sutures for medical applications. Institutes outside Greece, 2014. http://hdl.handle.net/10442/hedi/61852